Anna Nardelli

1.2k total citations
43 papers, 832 citations indexed

About

Anna Nardelli is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Oncology. According to data from OpenAlex, Anna Nardelli has authored 43 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Surgery and 9 papers in Oncology. Recurrent topics in Anna Nardelli's work include Radiopharmaceutical Chemistry and Applications (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Medical Imaging Techniques and Applications (5 papers). Anna Nardelli is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Medical Imaging Techniques and Applications (5 papers). Anna Nardelli collaborates with scholars based in Italy, United States and Belgium. Anna Nardelli's co-authors include Fulvio Lauretani, Giovanni Storto, Alessandra Pelagalli, Antonella Zannetti, Rosj Gallicchio, Gian Paolo Ceda, Daniela Capacchione, Enrico Lucarelli, Antonio Giordano and Giulio Pioli and has published in prestigious journals such as Radiology, International Journal of Molecular Sciences and The American Journal of Medicine.

In The Last Decade

Anna Nardelli

43 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Nardelli Italy 19 267 138 132 126 123 43 832
Alptekin Gürsoy Türkiye 23 446 1.7× 62 0.4× 268 2.0× 156 1.2× 138 1.1× 67 1.6k
James Lee United States 19 375 1.4× 63 0.5× 126 1.0× 140 1.1× 83 0.7× 55 1.1k
África Muxí Spain 19 233 0.9× 170 1.2× 104 0.8× 202 1.6× 124 1.0× 59 970
Georgios Arsos Greece 17 256 1.0× 81 0.6× 68 0.5× 201 1.6× 74 0.6× 66 772
Marcelo Tatit Sapienza Brazil 19 210 0.8× 354 2.6× 82 0.6× 103 0.8× 218 1.8× 106 1.1k
Se Hwa Kim South Korea 20 219 0.8× 60 0.4× 238 1.8× 175 1.4× 116 0.9× 54 937
Hariharan Thangarajah United States 14 348 1.3× 47 0.3× 300 2.3× 103 0.8× 88 0.7× 23 1.3k
Tomohiro Nakamura Japan 20 328 1.2× 171 1.2× 213 1.6× 86 0.7× 169 1.4× 87 1.3k
Harald Lahner Germany 21 240 0.9× 162 1.2× 164 1.2× 489 3.9× 72 0.6× 69 1.5k

Countries citing papers authored by Anna Nardelli

Since Specialization
Citations

This map shows the geographic impact of Anna Nardelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Nardelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Nardelli more than expected).

Fields of papers citing papers by Anna Nardelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Nardelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Nardelli. The network helps show where Anna Nardelli may publish in the future.

Co-authorship network of co-authors of Anna Nardelli

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Nardelli. A scholar is included among the top collaborators of Anna Nardelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Nardelli. Anna Nardelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omodei, Daniela, Caterina De Rosa, Roberta Buono, et al.. (2024). Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer. Cancers. 16(23). 3941–3941. 1 indexed citations
2.
Nardelli, Anna, et al.. (2024). The prevalence of solid tumors and hematologic malignancies among patients with Down syndrome: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 205. 104558–104558. 2 indexed citations
3.
4.
Gallicchio, Rosj, Anna Nardelli, Giovanni Calice, et al.. (2021). F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study. European Journal of Radiology. 136. 109564–109564. 3 indexed citations
5.
Russi, Sabino, Henu Kumar Verma, Simona Laurino, et al.. (2019). Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. International Journal of Molecular Sciences. 20(15). 3736–3736. 44 indexed citations
6.
Gallicchio, Rosj, Anna Nardelli, Daniela Capacchione, et al.. (2017). F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer. European Journal of Radiology. 93. 107–113. 20 indexed citations
7.
Pioli, Giulio, Fulvio Lauretani, Francesca Pellicciotti, et al.. (2016). Modifiable and non-modifiable risk factors affecting walking recovery after hip fracture. Osteoporosis International. 27(6). 2009–2016. 48 indexed citations
8.
Lauretani, Fulvio, Cosimo Costantino, Andrea Ticinesi, et al.. (2015). Parkinson’s disease (PD) with dementia and falls is improved by AChEI? A preliminary study report. Aging Clinical and Experimental Research. 28(3). 551–555. 10 indexed citations
9.
Pelagalli, Alessandra, Anna Nardelli, Crescenzo D’Alterio, et al.. (2015). A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion. Cancer Letters. 370(1). 100–107. 72 indexed citations
10.
Lauretani, Fulvio, et al.. (2014). Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation. Current Drug Targets. 15(10). 943–947. 14 indexed citations
11.
Lauretani, Fulvio, Gian Paolo Ceda, Livia Ruffini, et al.. (2014). Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons. Current Pharmaceutical Design. 20(19). 3149–3164. 10 indexed citations
12.
Lauretani, Fulvio, Gian Paolo Ceda, Anna Nardelli, & Marcello Maggio. (2014). Should post-mortem brain dissection be performed in Parkinson’s disease with atypical dementia?. Aging Clinical and Experimental Research. 27(1). 103–105. 1 indexed citations
13.
Gallicchio, Rosj, Daniela Capacchione, Anna Nardelli, et al.. (2013). F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer. International Journal of Colorectal Disease. 28(12). 1699–1705. 6 indexed citations
14.
Savino, Elisabetta, Emilio Martini, Fulvio Lauretani, et al.. (2013). Handgrip Strength Predicts Persistent Walking Recovery After Hip Fracture Surgery. The American Journal of Medicine. 126(12). 1068–1075.e1. 86 indexed citations
15.
Lauretani, Fulvio, et al.. (2011). Parkinson's disease (PD) in the elderly: An example of geriatric syndrome (GS)?. Archives of Gerontology and Geriatrics. 54(1). 242–246. 28 indexed citations
16.
Nardelli, Anna, et al.. (2010). Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90. Applied Radiation and Isotopes. 69(1). 52–55. 3 indexed citations
17.
Lauretani, Fulvio, et al.. (2010). Capturing side-effect of medication to identify persons at risk of delirium. Aging Clinical and Experimental Research. 22(5-6). 456–458. 21 indexed citations
18.
Speranza, A., et al.. (2009). Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: Amino-oxi peptide labelling prosthetic group. Applied Radiation and Isotopes. 67(9). 1664–1669. 14 indexed citations
19.
Lauretani, Fulvio, et al.. (2009). Is Non-Convulsive Status Epilepticus (NCSE) undertreated in patients affected by dementia?. Aging Clinical and Experimental Research. 21(4-5). 363–364. 3 indexed citations
20.
Storto, Giovanni, Amalia De Renzo, Teresa Pellegrino, et al.. (2009). Assessment of Metabolic Response to Radioimmunotherapy with90Y–Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non–Hodgkin Lymphoma. Radiology. 254(1). 245–252. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alptekin Gürsoy Breakdown of academic impact, for papers by James Lee Breakdown of academic impact, for papers by África Muxí Breakdown of academic impact, for papers by Georgios Arsos Breakdown of academic impact, for papers by Marcelo Tatit Sapienza Breakdown of academic impact, for papers by Se Hwa Kim Breakdown of academic impact, for papers by Hariharan Thangarajah Breakdown of academic impact, for papers by Tomohiro Nakamura Breakdown of academic impact, for papers by Harald Lahner
Rankless by CCL
2026